Ironwood Pharmaceuticals
IRWD
IRWD
190 hedge funds and large institutions have $1.55B invested in Ironwood Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 67 increasing their positions, 65 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
190
Holders Change
-12
Holders Change %
-5.94%
% of All Funds
3.84%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
24
Increased
67
Reduced
65
Closed
36
Calls
$12.2M
Puts
$5.81M
Net Calls
+$6.39M
Net Calls Change
-$301K
Top Buyers
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$13.5M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$11.7M |
| 3 |
Man Group
London,
United Kingdom
|
+$10.4M |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$8.08M |
| 5 |
BM
Bridger Management
New York
|
+$7.67M |
Top Sellers
| 1 |
SPC
Slate Path Capital
New York
|
-$27.2M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$26.9M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$15.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.2M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
-$13.1M |
